236 related articles for article (PubMed ID: 7506116)
1. Prognostic significance of the overexpression of c-erbB-2 protein in adenocarcinoma of the uterine cervix.
Kihana T; Tsuda H; Teshima S; Nomoto K; Tsugane S; Sonoda T; Matsuura S; Hirohashi S
Cancer; 1994 Jan; 73(1):148-53. PubMed ID: 7506116
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of c-erbB-2 protein in gastric cancer. Its correlation with long-term survival of patients.
Uchino S; Tsuda H; Maruyama K; Kinoshita T; Sasako M; Saito T; Kobayashi M; Hirohashi S
Cancer; 1993 Dec; 72(11):3179-84. PubMed ID: 7902202
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of DNA ploidy and c-erbB-2 oncoprotein overexpression in adenocarcinoma of Barrett's esophagus.
Nakamura T; Nekarda H; Hoelscher AH; Bollschweiler E; Harbeck N; Becker K; Siewert JR; Harbec N [corrected to Harbeck N]
Cancer; 1994 Apr; 73(7):1785-94. PubMed ID: 7907940
[TBL] [Abstract][Full Text] [Related]
4. Altered expression of nm23-H1 and c-erbB-2 proteins have prognostic significance in adenocarcinoma but not in squamous cell carcinoma of the uterine cervix.
Mandai M; Konishi I; Koshiyama M; Komatsu T; Yamamoto S; Nanbu K; Mori T; Fukumoto M
Cancer; 1995 May; 75(10):2523-9. PubMed ID: 7736397
[TBL] [Abstract][Full Text] [Related]
5. Amplification of the c-erbB-2 gene in gastric carcinoma: correlation with survival.
Tsugawa K; Fushida S; Yonemura Y
Oncology; 1993; 50(6):418-25. PubMed ID: 7901825
[TBL] [Abstract][Full Text] [Related]
6. Expression of c-myc, epidermal growth factor receptor and c-erbB-2 in human endometrial carcinoma and cervical adenocarcinoma.
Sato S; Ito K; Ozawa N; Yajima A; Sasano H
Tohoku J Exp Med; 1991 Oct; 165(2):137-45. PubMed ID: 1687493
[TBL] [Abstract][Full Text] [Related]
7. Relationship of C-erbB-2 protein expression and gene amplification to invasion and metastasis in human gastric cancer.
Mizutani T; Onda M; Tokunaga A; Yamanaka N; Sugisaki Y
Cancer; 1993 Oct; 72(7):2083-8. PubMed ID: 8397058
[TBL] [Abstract][Full Text] [Related]
8. Oncogene alterations in carcinomas of the uterine cervix: overexpression of the epidermal growth factor receptor is associated with poor prognosis.
Kersemaekers AM; Fleuren GJ; Kenter GG; Van den Broek LJ; Uljee SM; Hermans J; Van de Vijver MJ
Clin Cancer Res; 1999 Mar; 5(3):577-86. PubMed ID: 10100709
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical study on overexpression of c-erbB-2 protein in human breast cancer: its correlation with gene amplification and long-term survival of patients.
Tsuda H; Hirohashi S; Shimosato Y; Tanaka Y; Hirota T; Tsugane S; Shiraishi M; Toyoshima K; Yamamoto T; Terada M
Jpn J Cancer Res; 1990 Apr; 81(4):327-32. PubMed ID: 1973161
[TBL] [Abstract][Full Text] [Related]
10. Detection of c-erbB-2/neu and fibroblast growth factor-3/INT-2 but not epidermal growth factor receptor gene amplification in endometrial cancer by differential polymerase chain reaction.
Esteller M; García A; Martínez i Palones JM; Cabero A; Reventós J
Cancer; 1995 Apr; 75(8):2139-46. PubMed ID: 7697605
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of c-erbB-2 expression in uterine cervical carcinoma.
Hale RJ; Buckley CH; Fox H; Williams J
J Clin Pathol; 1992 Jul; 45(7):594-6. PubMed ID: 1355495
[TBL] [Abstract][Full Text] [Related]
12. Neu (c-erbB-2), a tumor marker in carcinoma of the female breast.
Maguire HC; Greene MI
Pathobiology; 1990; 58(6):297-303. PubMed ID: 1981830
[TBL] [Abstract][Full Text] [Related]
13. An analysis of HER2 amplification in cervical adenocarcinoma: correlation with clinical outcomes and the International Endocervical Adenocarcinoma Criteria and Classification.
Shi H; Shao Y; Lu W; Lu B
J Pathol Clin Res; 2021 Jan; 7(1):86-95. PubMed ID: 33089969
[TBL] [Abstract][Full Text] [Related]
14. [Overexpression of c-erbB-2 oncogene in primary ovarian cancers: incidence and prognostic significance in 243 patients].
Meden H; Marx D; Rath W; Kuhn W; Hinney B; Schauer A
Geburtshilfe Frauenheilkd; 1992 Nov; 52(11):667-73. PubMed ID: 1360438
[TBL] [Abstract][Full Text] [Related]
15. Uterine papillary serous adenocarcinoma. A 10-case study of p53 and c-erbB-2 expression and DNA content.
Prat J; Oliva E; Lerma E; Vaquero M; Matías-Guiu X
Cancer; 1994 Sep; 74(6):1778-83. PubMed ID: 7915964
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical study of c-erbB-2 oncoprotein overexpression in human major salivary gland carcinoma: an indicator of aggressiveness.
Sugano S; Mukai K; Tsuda H; Hirohashi S; Furuya S; Shimosato Y; Ebihara S; Takeyama I
Laryngoscope; 1992 Aug; 102(8):923-7. PubMed ID: 1353853
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of epidermal growth factor receptor (EGFR) and c-erbB-2 protein overexpression in adenocarcinoma of the uterine cervix.
Altavilla G; Castellan L; Wabersich J; Marchetti M; Onnis A
Eur J Gynaecol Oncol; 1996; 17(4):267-70. PubMed ID: 8856301
[TBL] [Abstract][Full Text] [Related]
18. c-erbB-2 Oncoprotein expression is associated with poor prognosis in squamous cell carcinoma of the cervix.
Oka K; Nakano T; Arai T
Cancer; 1994 Feb; 73(3):664-71. PubMed ID: 7905364
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of Bmi-1 in uterine cervical cancer: correlation with clinicopathology and prognosis.
Zhang X; Wang CX; Zhu CB; Zhang J; Kan SF; Du LT; Li W; Wang LL; Wang S
Int J Gynecol Cancer; 2010 Dec; 20(9):1597-603. PubMed ID: 21370603
[TBL] [Abstract][Full Text] [Related]
20. Correlation between c-erbB-2 amplification and risk of recurrent disease in node-negative breast cancer.
Paterson MC; Dietrich KD; Danyluk J; Paterson AH; Lees AW; Jamil N; Hanson J; Jenkins H; Krause BE; McBlain WA
Cancer Res; 1991 Jan; 51(2):556-67. PubMed ID: 1670762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]